CGT Global News

Featured Post

CGT Sourcing Guide 2025: How to Build a Resilient Supply Chain Amid Tariff Pressures

By camerontucker | June 4, 2025 | Comments Off on CGT Sourcing Guide 2025: How to Build a Resilient Supply Chain Amid Tariff Pressures
CGT Sourcing Guide 2025: How to Build a Resilient Supply Chain Amid Tariff Pressures By CGT Global

By CGT GlobalThe latest round of U.S. tariffs didn’t just shake up the headlines—it shook the very foundations of global pharma supply chains. And while most of the buzz has focused on traditional drugmakers, let’s be…

Read More

How Natural Killer Cells are Revolutionizing Cancer Treatment

By camerontucker | May 23, 2025 | Comments Off on How Natural Killer Cells are Revolutionizing Cancer Treatment
blog picture for nk cancer cells

By Joanna Wirkus What makes Natural Killer (NK) Cells the Perfect Weapon Against Cancer? Unlike the T cells of the adaptive immune system, innate natural killer (NK) cells protect the body against tumors without prior programming.…

Read More

How to Improve Humanized Mouse Engraftment: CD34+ Cell Sourcing & Viability Tips

By camerontucker | May 16, 2025 | Comments Off on How to Improve Humanized Mouse Engraftment: CD34+ Cell Sourcing & Viability Tips
Boosting Humanized Mice Engraftment: What Every Scientist Should Know

By: Joanna Wirkus  Simple Steps to Significantly Improve Humanized Mice Engraftment Success  Previously in “Overcoming Challenges with Animal Models in Research”, we covered why animal models with human immune systems have significantly improved the translation of…

Read More

Cord Blood CD34+ Cells: High Viability for Humanized Mouse Models

By camerontucker | May 13, 2025 | Comments Off on Cord Blood CD34+ Cells: High Viability for Humanized Mouse Models
blog cover for cord blood cd34 cells

By: Joanna Wirkus The Rise of Cord Blood CD34+ Cells in Humanized Mouse Models and Cell Therapy Innovation Scientists in the late 1980’s discovered that umbilical cord blood derived stem cells had high proliferative…

Read More